Researchers are building AI-powered robot labs. What does this mean for science?

Ginkgo Bioworks (NYSE:DNA) reported first-half 2026 cash burn of $93M, down 3% from $96M a year earlier. Management said Q1 cash burn included a $14M Google Cloud payment tied to an amended 2025 commitment that cut future minimums by over $100M and extended the term to six years. Ginkgo expanded its Nebula lab to 105 racks and raised $17M via an ATM.

Ginkgo Bioworks Holdings, Inc. (DNA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991earningspr.htm EX-99.1 Document Exhibit 99.1 Ginkgo Bioworks Reports Second Quarter 2026 Results, Wins Government Contracts to Build Autonomous Labs at MIT, Caltech, Northwestern, and University of Maryland Ginkgo provides an update on its second quarter financial

NPR reports that Ginkgo Bioworks in Boston is developing an “autonomous lab” where AI directs robots to run experiments, including drug discovery, fertilizer microbes, and protein design. Founders say AI is moving from automating tasks to generating hypotheses, including an OpenAI collaboration using GPT‑5 to design a cell-free protein synthesis reaction. Stanford’s Drew Endy warns of biosecurity and skills-loss risks.

NPR reports that researchers at Ginkgo Bioworks in Boston are building “autonomous labs” where AI and robots handle tasks such as pipetting, scheduling experiments, and even generating hypotheses. Founders Jason Kelly and Reshma Shetty say AI is being used to design experiments overnight and to collaborate with OpenAI on cell-free protein synthesis. Stanford’s Drew Endy warns about biosecurity and loss of scientific know-how.

Eli Lilly said it will seek FDA approval in Q1 2027 for retatrutide, its next anti-obesity drug. In a phase 3 study, retatrutide showed average weight loss up to 28.3% over 80 weeks, including in patients with diabetes. The article also cites Lilly’s Q2 revenue of $23B (+48% YoY) and adjusted EPS of $8.38 (+33%).

Joby Aviation (JOBY) announced a strategic partnership with Atoms, founded by former Uber CEO Travis Kalanick, to acquire and develop a network of air taxi vertiports in the US. Initial targets include Florida, New York, Texas, and California, tied to Joby’s eVTOL Integration Pilot Program launch. Joby said the sites will be multimodal hubs with charging power.